Technical Analysis for GOVX - GeoVax Labs, Inc.

Grade Last Price % Change Price Change
D 0.90 -3.74% -0.04
GOVX closed down 3.74 percent on Monday, February 6, 2023, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Calm After Storm Range Contraction -3.74%
Wide Bands Range Expansion -3.74%
Up 3 Days in a Row Strength -3.74%
Up 4 Days in a Row Strength -3.74%
Calm After Storm Range Contraction -2.17%
Inside Day Range Contraction -2.17%
Wide Bands Range Expansion -2.17%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 2 hours ago
Possible NR7 about 4 hours ago
Fell Below Previous Day's Low about 6 hours ago
60 Minute Opening Range Breakdown about 6 hours ago
Down 3% about 6 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GeoVax Labs, Inc. Description

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U.S. Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; U.S. Department of Defense; Geneva Foundation; Enesi Pharma; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Clinical Medicine Infectious Diseases Immunotherapies Vaccines Allergy Hepatitis B Viruses Department Of Defense HIV Immunodeficiency Virus Fever U.S. Department Of Defense Virology Malaria Ebola Scripps Zika Chronic Hepatitis Hiv Vaccine Vaccinia

Is GOVX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.3
52 Week Low 0.1
Average Volume 2,134,493
200-Day Moving Average 1.14
50-Day Moving Average 0.72
20-Day Moving Average 0.81
10-Day Moving Average 0.86
Average True Range 0.12
RSI 56.33
ADX 48.21
+DI 37.63
-DI 7.85
Chandelier Exit (Long, 3 ATRs) 1.03
Chandelier Exit (Short, 3 ATRs) 0.96
Upper Bollinger Bands 1.02
Lower Bollinger Band 0.60
Percent B (%b) 0.72
BandWidth 52.43
MACD Line 0.05
MACD Signal Line 0.04
MACD Histogram 0.0128
Fundamentals Value
Market Cap 12.44 Million
Num Shares 13.8 Million
EPS -5.62
Price-to-Earnings (P/E) Ratio -0.16
Price-to-Sales 4.33
Price-to-Book 0.00
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.98
Resistance 3 (R3) 0.98 0.95 0.96
Resistance 2 (R2) 0.95 0.93 0.95 0.96
Resistance 1 (R1) 0.93 0.92 0.92 0.93 0.95
Pivot Point 0.90 0.90 0.90 0.90 0.90
Support 1 (S1) 0.88 0.88 0.87 0.88 0.85
Support 2 (S2) 0.85 0.87 0.85 0.84
Support 3 (S3) 0.83 0.85 0.84
Support 4 (S4) 0.83